Haiyan Tang, Esq.

About

Dr. Haiyan Tang is the managing partner and chief representative of Quinn Emanuel’s Shanghai office, with a distinguished record in high-stakes cross-border litigation, arbitration, and government enforcement. A Yale-trained neuroscientist-turned-litigator, Dr. Tang is widely recognized for her expertise in intellectual property disputes, trade secret litigation, complex commercial cases, and international arbitration. She has represented multinational corporations, leading technology companies, private equity funds, and high-net-worth individuals across the U.S., China, and beyond. Her cases span diverse industries and technologies, including biotech, pharmaceuticals, semiconductors, and software. She is also an appointed arbitrator with the China International Economic and Trade Arbitration Commission (CIETAC), the Shanghai International Arbitration Center (SHIAC), and the Hong Kong International Arbitration Centre (HKIAC).

Beyond litigation, Dr. Tang is a top advisor on U.S. government investigations and compliance matters involving the Securities and Exchange Commission (SEC), the Department of Justice (DOJ), and the Food and Drug Administration (FDA). She has led numerous government and internal investigations and developed compliance programs for major companies in the healthcare and tech sectors. Her prior roles include Chief Legal & Compliance Officer of a top healthcare-focused private equity fund and Acting Regional Compliance Director at a global biopharmaceutical company. She is a frequent speaker in both English and Chinese and has been recognized by Chambers, Legal 500, and Global Investigations Review among the world’s leading practitioners. Dr. Tang is admitted to the California Bar and the U.S. Patent and Trademark Office.